Pharmaceutical - AstraZeneca, Oncology

Filter

Current filters:

AstraZenecaOncology

Popular Filters

1 to 25 of 77 results

NICE comes back with different views on Tarceva and Iressa for NSCLC

NICE comes back with different views on Tarceva and Iressa for NSCLC

07-08-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) is consulting again…

AstraZenecaIressaOncologyPharmaceuticalPricingRegulationRocheTarcevaUK

AstraZeneca and Kyowa Hakko Kirin sign immunotherapy research deal

AstraZeneca and Kyowa Hakko Kirin sign immunotherapy research deal

30-07-2014

Anglo-Swedish pharma major AstraZeneca today announced that it has entered into a clinical study collaboration…

AstraZenecaBriggs MorrisonImmunologyJapanKyowa Hakko KirinOncologyPharmaceuticalResearchUK

Negative view from FDA advisory for AstraZeneca’s olaparib

Negative view from FDA advisory for AstraZeneca’s olaparib

26-06-2014

There was disappointment for Anglo-Swedish pharma major AstraZeneca yesterday when a US Food and Drug…

AstraZenecaLynparzaolaparibOncologyPharmaceuticalRegulationUSA

Gustave Roussy and AstraZeneca form joint oncology research alliance

Gustave Roussy and AstraZeneca form joint oncology research alliance

05-06-2014

The France-based Gustave Roussy comprehensive cancer center and Anglo-Swedish drug major AstraZeneca…

AstraZenecaOncologyPharmaceuticalResearch

AstraZeneca showcases much awaited oncology pipeline at ASCO 2014

AstraZeneca showcases much awaited oncology pipeline at ASCO 2014

03-06-2014

Anglo-Swedish drug major AstraZeneca provided an update on the rapid development of its oncology pipeline…

AstraZenecaAZD9291MED14736MedImmuneOncologyPharmaceuticalResearchtremelimumab

AstraZeneca stresses confidence in independence, highlighting strong R&D pipeline

15-05-2014

Anglo-Swedish pharma major AstraZeneca, the subject of the controversial takeover attempt by Pfizer,…

AstraZenecaCardio-vascularMergers & AcquisitionsMetabolicsOncologyPharmaceuticalResearchRespiratory and Pulmonary

MedImmune and Incyte to collaborate on immunotherapy

MedImmune and Incyte to collaborate on immunotherapy

14-05-2014

MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

AstraZenecaBahija JallalIncyteL1LicensingMajorMedImmuneOncologyPharmaceuticalTumorTumorsUKUSA

US FDA grants priority review for AstraZeneca’s olaparib

US FDA grants priority review for AstraZeneca’s olaparib

30-04-2014

The US Food and Drug Administration has granted Priority Review for Anglo-Swedish drug major AstraZeneca’s…

AstraZenecaolaparibOncologyPharmaceuticalRegulationUK

AstraZeneca says Pfizer offer “very significantly” undervalues the firm

28-04-2014

Confirming a takeover approach from the US drugs giant, Anglo-Swedish pharma major AstraZeneca issued…

AstraZenecaMergers & AcquisitionsOncologyPfizerPharmaceutical

Potential to fast-track drugs in new Cancer Research UK partnership with AstraZeneca and Pfizer

Potential to fast-track drugs in new Cancer Research UK partnership with AstraZeneca and Pfizer

17-04-2014

British charity Cancer Research UK has joined forces with Anglo-Swedish drug major AstraZeneca and US…

AstraZenecaCancerHealthMajorMedicineOncologyPfizerPharmaceuticalPharmacologyResearchUK

Interview: AstraZeneca’s oncology expert Susan Galbraith on the company’s exciting pipeline

Interview: AstraZeneca’s oncology expert Susan Galbraith on the company’s exciting pipeline

11-04-2014

The full year report from Anglo-Swedish drug major AstraZeneca (LSE: AZN) in February was full of optimism.…

AstraZenecaInterviewsIressaOncologyPharmaceuticalUK

Japanese approval for Forxiga and Lonsurf

24-03-2014

Anglo-Swedish drug major AstraZeneca says that Japanese Ministry of Health, Labor and Welfare approved…

Asia-PacificAstraZenecaDiabetesForxigaJapanLonsurfOncologyOno PharmaceuticalOtsukaPharmaceuticalRegulationTaiho Pharmaceutical

AstraZeneca to establish cancer research program with Korea’s HIDI

AstraZeneca to establish cancer research program with Korea’s HIDI

07-03-2014

Anglo-Swedish pharma major AstraZeneca has signed a memorandum of understanding (MoU) with the South…

Asia-PacificAstraZenecaOncologyPharmaceuticalResearch

UK’s NICE consults on updating guidance for Tarceva and Iressa

UK’s NICE consults on updating guidance for Tarceva and Iressa

04-02-2014

The UK’s National Institute for Health and Care Excellence (NICE) said this morning that it is reviewing…

AstraZenecadocetaxelIressaOncologyPharmaceuticalRegulationRocheTarcevaUK

AstraZeneca in licensing deal for MALT1 inhibitors; closes Bangalore R&D site

AstraZeneca in licensing deal for MALT1 inhibitors; closes Bangalore R&D site

31-01-2014

Belgium-based VIB, a non-profit research institute in life sciences, and the Center for Drug Design and…

Asia-PacificAstraZenecaIndiaInflammatory diseasesOncologyPharmaceuticalResearchTropical diseases

Hutchison China MediTech upgraded by Panmure

30-01-2014

In a new report on Chinese pharmaceutical company Hutchison China MediTech, Panmure Gordon analyst Savvas…

AstraZenecaFinancialHutchison MediTechOncologyPharmaceuticalResearchvolitinib

Lung cancer treatment takes another forward step in New Zealand

Lung cancer treatment takes another forward step in New Zealand

09-01-2014

Improvements in lung cancer treatment are set to continue with a decision for New Zealand’s Pharmaceutical…

Asia-PacificAstraZenecaFinancialHealthcareIressaOncologyPharmaceuticalRocheTarceva

Horizon Discovery inks second cancer research deal with AstraZeneca

Horizon Discovery inks second cancer research deal with AstraZeneca

07-01-2014

UK-based Horizon Discovery and AstraZeneca have entered into a research, collaboration and license agreement…

AstraZenecaHorizon DiscoveryLicensingOncologyPharmaceuticalResearch

Probiodrug sells its CDK9 inhibitor program to AstraZeneca

Probiodrug sells its CDK9 inhibitor program to AstraZeneca

06-01-2014

Privately-held German company Probiodrug says it has transferred its experimental cyclin-dependent kinase…

AstraZenecaInflammatory diseasesMergers & AcquisitionsOncologyPharmaceuticalProbiodrug

Cancer Research UK to trial AstraZeneca asthma drug candidate for kidney cancer

Cancer Research UK to trial AstraZeneca asthma drug candidate for kidney cancer

27-12-2013

Cancer Research UK and Cancer Research Technology (the charity’s development and commercialization…

AstraZenecaAZD2098Cancer Research TechnologyOncologyPharmaceuticalResearch

SABCS 2013: Arimidex cuts breast cancer risk 53% in high risk women

SABCS 2013: Arimidex cuts breast cancer risk 53% in high risk women

13-12-2013

A study of 4,000 women found that anastrozole, Anglo-Swedish drug major AstraZeneca’s now off-patent…

AnastrozoleArimidexAstraZenecaOncologyPharmaceuticalResearchtamoxifen

1 to 25 of 77 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top